GEGAX
Price
$20.37
Change
+$0.43 (+2.16%)
Updated
Jul 31 closing price
Net Assets
1.02B
VEMAX
Price
$48.64
Change
+$0.61 (+1.27%)
Updated
Jul 31 closing price
Net Assets
163.32B
Interact to see
Advertisement

GEGAX vs VEMAX

GEGAX vs VEMAX Comparison Chart in %
View a ticker or compare two or three
VS
GEGAX vs. VEMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEGAX is a Hold and VEMAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 163B vs. GEGAX (1.02B). VEMAX pays higher dividends than GEGAX: VEMAX (2.32) vs GEGAX (0.66). GEGAX was incepted earlier than VEMAX: GEGAX (14 years) vs VEMAX (20 years). GEGAX (1.43) is less costly to investors than VEMAX (0.13). GEGAX is a more actively managed with annual turnover of: 35.00 vs. VEMAX (6.00). GEGAX has a lower initial minimum investment than VEMAX: GEGAX (1000) vs VEMAX (3000). GEGAX annual gain was more profitable for investors over the last year : 34.84 vs. VEMAX (19.34). VEMAX return over 5 years is better than : 27.49 vs. GEGAX (4.83).
GEGAXVEMAXGEGAX / VEMAX
Total Expense Ratio1.380.131,062%
Annual Report Gross Expense Ratio1.430.131,100%
Fund Existence14 years20 years-
Gain YTD22.1229.106243%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRA1000N/A-
Net Assets1.02B163B1%
Annual Yield % from dividends0.662.3228%
Returns for 1 year34.8419.34180%
Returns for 3 years55.6846.41120%
Returns for 5 years4.8327.4918%
Returns for 10 years67.1489.0875%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDFGX30.490.46
+1.53%
BlackRock Capital Appreciation Inv A
OIEQX28.620.24
+0.85%
JPMorgan Equity Income R4
GTLOX23.840.06
+0.25%
Glenmede Disciplined US Eq Ptf
CSDGX17.130.04
+0.23%
Copeland SMID Cap Dividend Growth A
GTMUX24.78-0.03
-0.12%
Goldman Sachs Small/Mid Cap Growth R6